OTC
IONS icon

Opera Trading Capital’s Ionis Pharmaceuticals IONS Stock Holding History

Opera Trading Capital’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-11,134
Closed -$574K – 128
2018
Q3 		$574K Buy
+11,134
New +$523K 0.11% 76
2016
Q3 		– Sell
-1,553
Closed -$36K – 123
2016
Q2 		$36K Sell
1,553
-1,339
-46% -$43.2K 0.01% 107
2016
Q1 		$117K Buy
2,892
+1,735
+150% +$70.5K 0.03% 106
2015
Q4 		$71K Buy
+1,157
New +$62.4K 0.01% 84

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Opera Trading Capital's IONS Position: Q4 2018 in Review

Opera Trading Capital sold out of Ionis Pharmaceuticals (IONS) in Q4 2018, closing a stake of 11,134 shares — an estimated $574K sold.

Opera Trading Capital first reported a position in IONS in Q4 2015 and held it in 4 quarters. The position peaked at $574K in Q3 2018. 329 funds tracked by Wall St. Rank hold IONS as of Q4 2018.

  • Opera Trading Capital reported no remaining Ionis Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • Opera Trading Capital sold 11,134 Ionis Pharmaceuticals shares in Q4 2018, an estimated $574K.
  • Opera Trading Capital first reported a position in Ionis Pharmaceuticals in Q4 2015 and held it in 4 quarters.
  • Opera Trading Capital's Ionis Pharmaceuticals position peaked at $574K in Q3 2018.
  • 329 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2018.

Based on Opera Trading Capital's 13F filing for Q4 2018, filed 22 Jan 2019.